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MLS301 Transfusion Medicine 




30 Multiple Choice Questions: ½mark each 
Total No of Marks for this section: 15  
 
• Answer ALL thirty (30) questions in this section on the multiple choice answer sheet 
provided. Please ensure to write your names and student number on the answer sheet 
• Note that ALL questions in this section are of equal value as indicated. 
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Section B 
Short Answer Questions 
Total No of Marks for this section: 60   
 
• Answer ALL twelve (12) questions in this section; and on the space provided on the exam 
paper. 
• Note that the question values are indicated. 




A sample from Robert Smith, Hospital Number 2659874, date of birth 25/01/1948 demonstrated a 
positive antibody screen during routine pre-admission screening for a total hip replacement 
operation.  Results of testing with an antibody identification panel are shown.  Refer to his 
antibody identification panel to answer the following questions: 
a) At what phase are the reactions occurring? 
 
(Mark: 0.5) 




c) Is this an alloantibody or an autoantibody? 
 
(Mark: 0.5) 
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Question 2 
Fill in the interpretations of the following ABO and D group reactions. 
 
Anti-A Anti-B Anti-D A1 cells B cells Group 
12 0 12 0 12  
0 0 0 12 12  
12 0 0 0 12  
12 12 0 0 0  
0 12 0 12 0  
0 0 12 12 12  
12 12 12 0 0  
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Question 3 
The following reactions were obtained by testing red cells from a patient with Rh blood group 
antisera: 
 
Anti-D Anti-C Anti-E Anti-c Anti-e 
12 12 0 0 12 
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A 60 year old woman with anaemia is admitted to hospital.  Her Hb is 64g/L and she has been 
experiencing ongoing subtle gastrointestinal bleeding over many weeks.  Her doctor requests two 
units of red cells for transfusion before going to theatre.   
 
Upon testing her blood group is B Positive and her antibody screen is negative. 
 
Her previous transfusion history is checked and it’s discovered that she had an anti-Jk(b) 
previously detected 3 years ago. 
 
In your red cell inventory you don’t have any group B red cells in stock as another patient has used 
all of them. 
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A 24 year old male has been in a car accident and the doctors are suspecting that he has a 
fractured pelvis and a ruptured spleen.  A sample and request are sent to the lab for ‘group and 
hold’ testing. 
 
a) What laboratory tests are performed for a group and hold? 
 
(Mark: 0.5) 
The following ABO and D results are obtained: 
 
Anti-A Anti-B Anti-D A1 cells B cells 
12 0 12 0 12 
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A patient receives two units of red blood cells as his Hb dropped to 71g/L after surgery on his hip.  
Pre-transfusion indicated his blood group was O Positive and his antibody screen was negative.  He 
is discharged two days later with a Hb of 91g/L.    
Seven days later he presents to the Emergency Department with symptoms of jaundice and 
lethargy.  No evidence of bleeding is identified.  A full blood count examination is performed which 
shows the patient’s Hb is 65g/L. 









c) After testing the patient’s post-transfusion specimen, the antibody screen is positive.  
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Patient Lara Bungle has a positive pregnancy screening test and has been referred to the Antenatal 
Clinic at your hospital for her initial visit at 9 weeks gestation.  This is her first pregnancy. 




Results of prenatal testing indicated that Lara Bungle is group O Negative with a negative antibody 
screen.   
b) Does Lara need any additional laboratory testing performed during her pregnancy?  If so, 





Lara was seen again at the Antenatal Clinic at 28 weeks gestation.  Her antibody screen is repeated 
and found to be negative. 




12 weeks later Lara delivers a very healthy baby boy. 
d) What testing, if any, needs to be performed at the time of delivery? 
 
(Mark: 1) 
e) If Lara’s baby boy is found to be Rh Negative does Lara need to receive any further 
injections of Rh(D) Immunoglobulin?   
 
(Mark: 0.5) 
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b) A patient with thrombocytopaenia and bleeding presents to ED.  What blood component 
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b) List 2 non-immune-mediated adverse complications of transfusion: 
(Mark: 2) 
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Patient Kate Wilson, hospital number 193854, date of birth 13/10/1995 has presented to your 
hospital in advanced stages of labour. She has had no antenatal care during her pregnancy. A 
sample is taken for group and hold.   
 
Her group is O Positive and the antibody screen is positive. 
 
Results of testing with an antibody identification panel are shown.  Refer to her antibody 
identification panel to answer the following questions: 
 














Full phenotyping is performed with the following results: 
CDe (R1R1), K+, Fy(a+b+), Jk(a-b+), M+N+S+s+, P1-, Le(a-b+) 
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f) Does this antibody have any possible complications for the baby she is about to deliver?  If 
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Describe the rationale behind patient blood management (PBM).  Include the three pillars of PBM 
model in your answer. 
(Mark: 5) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
